Liquidia Settles Six Patent Lawsuits With United Therapeutics
Liquidia settled six lawsuits with United Therapeutics, ending multiyear litigation over sales of its Yutrepia drug. Liquidia shares surged nearly 30% this morning.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Liquidia Settles Lung Drug Dispute With United Therapeutics for $381 Million
The settlement ends six lawsuits over patents, trade secrets and contracts. Liquidia shares jumped nearly 40% in premarket trading Wednesday.